TLCR Reading Tools
How to cite item
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{53632}, author = {Brueckl, W., Reck, M., Rittmeyer, A., Kollmeier, J., Wesseler, C., Wiest, G., Christopoulos, P., Stenzinger, A., Tufman, A., Hoffknecht, P., Ulm, B., Reich, F., Ficker, J., Laack, E.}, title = {Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV}, journal = {Translational Lung Cancer Research}, volume = {10}, number = {7}, year = {2021}, url = {https://tlcr.amegroups.org/article/view/53632} }